ketoconazole has been researched along with Blood Diseases in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Zygomycosis is an opportunistic fungal infection that is increasingly reported in hematological patients." | 2.42 | Improved outcome of zygomycosis in patients with hematological diseases? ( Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gleissner, B | 1 |
Schilling, A | 1 |
Anagnostopolous, I | 1 |
Siehl, I | 1 |
Thiel, E | 1 |
Berenguer Berenguer, J | 1 |
2 reviews available for ketoconazole and Blood Diseases
Article | Year |
---|---|
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspe | 2004 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |